Department of Internal Medicine

Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. Taiwan 88%
3. Catheter Ablation 67%
4. Blood Pressure 43%
5. Heart Failure 33%
6. Hypertension 30%
7. Mortality 28%
8. Pulmonary Veins 28%
9. Renal Dialysis 25%
10. Cardiac Arrhythmias 23%
11. Kidney 22%
12. Therapeutics 21%
13. Tachycardia 21%
14. Stroke 20%
15. Cohort Studies 20%
16. Population 17%
17. Heart Atria 16%
18. Arrhythmogenic Right Ventricular Dysplasia 16%
19. Liver 15%
20. Serum 15%
21. Recurrence 15%
22. Hemodynamics 14%
23. Fibrosis 14%
24. Ventricular Tachycardia 14%
25. Type 2 Diabetes Mellitus 13%
26. Portal Hypertension 13%
27. Electrocardiography 12%
28. LCZ 696 12%
29. Blood Vessels 12%
30. Coronary Artery Disease 11%
31. Atrial Flutter 11%
32. Ghrelin 11%
33. Liver Cirrhosis 11%
34. Colorectal Neoplasms 11%
35. Portal Pressure 10%
36. Arm 10%
37. Chronic Renal Insufficiency 10%
38. Cardiology 10%
39. Infections 10%
40. Rheumatoid Arthritis 10%
41. Meta-Analysis 9%
42. Systemic Lupus Erythematosus 9%
43. Survival 9%
44. Lung 9%
45. Dialysis 9%
46. Chronic Kidney Failure 9%
47. Ligation 9%
48. Pulse Wave Analysis 9%
49. Tuberculosis 9%
50. Pressure 9%
51. Heart 9%
52. Stroke Volume 9%
53. Arterial Pressure 9%
54. Safety 8%
55. Cardiac Electrophysiologic Techniques 8%
56. Pharmaceutical Preparations 8%
57. Hospitalization 8%
58. Myocardial Infarction 8%
59. Guidelines 8%
60. Percutaneous Coronary Intervention 8%
61. Catheters 8%
62. Ambulatory Blood Pressure Monitoring 8%
63. Elderly 8%
64. Anticoagulants 8%
65. Cardiovascular Diseases 8%
66. Metabolic Syndrome 8%
67. Meningitis 7%
68. Veins 7%
69. Glucose 7%
70. des-n-octanoyl ghrelin 7%
71. Pneumonia 7%
72. Bile Ducts 7%
73. Atrial Remodeling 7%
74. Hemorrhage 7%
75. Cardiac Myocytes 7%
76. Retrospective Studies 7%
77. Neoplasms 7%
78. Apoptosis 7%
79. Superior Vena Cava 7%
80. Systematic Reviews 7%
81. Veterans Hospitals 7%
82. Stomach 7%
83. Vascular Stiffness 7%
84. Arteriovenous Fistula 7%
85. Creatinine 6%
86. Inflammation 6%
87. C-Reactive Protein 6%
88. National Health Programs 6%
89. Observational Studies 6%
90. Heart Rate 6%
91. Angiostrongyliasis 6%
92. Hepatic Encephalopathy 6%
93. Cardiomyopathies 6%
94. Randomized Controlled Trials 6%
95. Peritoneal Dialysis 6%
96. HIV 6%